From b260943b41232ff92831b97464d8a4ff5fb4992b Mon Sep 17 00:00:00 2001 From: veraort <77971709+veraort@users.noreply.github.com> Date: Thu, 25 Mar 2021 09:50:59 +0100 Subject: [PATCH] Update compliance_monitoring.md I made a list with the information I had collected from our seminar and what Markus Englund had already compiled in the issue #268. I have therefore simply listed Markus Englund and myself as contributors. I hope you agree with this @jmenglund. --- pages/your_problem/compliance_monitoring.md | 29 +++++++++++++++++++-- 1 file changed, 27 insertions(+), 2 deletions(-) diff --git a/pages/your_problem/compliance_monitoring.md b/pages/your_problem/compliance_monitoring.md index 37ce65238..f2e91c9b5 100644 --- a/pages/your_problem/compliance_monitoring.md +++ b/pages/your_problem/compliance_monitoring.md @@ -1,7 +1,8 @@ --- title: Compliance monitoring & measurement tags: [plan, researcher, data manager, policy officer] -contributors: [Christophe Trefois, Wei Gu, Pinar Alper] +contributors: [Christophe Trefois, Wei Gu, Pinar Alper, +Markus Englund, Vera Ortseifen] description: measure compliance to data management regulations and standards. --- @@ -26,7 +27,7 @@ By knowing their capabilities institutions can spot areas of improvement and dir * FAIR data * GO-FAIR Initiative provides a framework for designing [metrics for the evaluation of FAIRness](https://www.go-fair.org/2017/12/11/metrics-evaluation-fairness/). - * The [FAIRplus project](https://fairplus.github.io/cookbook-dev/intro) has identified a set of [FAIR Indicators](https://zenodo.org/record/3909563#.X8ABpi-ZNTY) for data. + * The [FAIRplus project](https://fairplus.github.io/cookbook-dev/intro) has identified a set of [FAIR Indicators](https://zenodo.org/record/3909563#.X8ABpi-ZNTY) for data. * [FAIR Evaluators](https://fairsharing.github.io/FAIR-Evaluator-FrontEnd/#!/evaluations) are an automated approach to evaluate FAIRness of data services. * Information Security, Data Protection, Accountability * [21 CFR part 11](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/part-11-electronic-records-electronic-signatures-scope-and-application) is a standard, which outlines criteria for electronic records in an IT system to be as valid as signed paper @@ -34,6 +35,30 @@ records. It is widely adopted in lab information systems and applications used i * [ISO 27001](https://www.iso.org/isoiec-27001-information-security.html) is an international standard for the management of information security. It is adopted by some universities and research institutes to certify their data centres. * [ISO/IEC 27018](http://data-reuse.eu/wp-content/uploads/2017/02/ISO-Standards.pdf) is a standard aimed to be a code of practice for protection of personally identifiable information (PII) in public clouds. +## How can I ethically access genetic resources of another country? + +### Description +With the enactment of the Convention on Biological Diversity (CBD) in 1993 the Access and Benefit-Sharing (ABS) was anchored as one of the goals. Article 3 of CBD clarifies, that states have sovereign rights over their own (biological & genetic) resources. Negotiations concluded in 2014 with the Nagoya Protocol on ABS). Since then, working with genetic resources and associated data of another country requires more preparatory measures. The aim of the Nagoya protocol is to ensure fair and equitable sharing of benefits arising from utilisation of genetic resources and from traditional knowledge associated with genetic resources. Many contries, as well as the EU, are parties of the Nagoya protocol and information on this can be found at the ABS Clearing House (https://absch.cbd.int/). By enactment of EU Regulation No. 511/2014, the obligations were implemented in the EU on 12.10.2014 (https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32014R0511). + + +### Considerations + +Associated data about a genetic resources with Access legislation in place also requires special attention. Since ABS regulations put high demands on documentation and is therefore time consuming, this needs to be taken into account when planning a research project. When negotiating the Mutually Agreed Terms, it is very important to think about the future reusability of the data. If ABS is relevant to the project it should be part of the data management plan. Moreover, when sharing data, it is important to include necessary metadata regarding ABS in order to make reuse of the data possible. + +ABS is not relevant for all genetic resources. It applies only to resources that have been accessed from a provider country after October 12, 2014. Some genetic resources are explicitly excluded, like for example human genomes, some crops and some viruses. Moreover, there are countries who are party of the Nagoya protocol, but have no ABS legislation in place. + + +### Solutions + +Plan: +* Allow extra time to familiarise yourself with the legal requirements. For more information take a look at the European documents https://ec.europa.eu/environment/nature/biodiversity/international/abs/index_en.htm and https://ec.europa.eu/environment/nature/biodiversity/international/abs/material_en.htm +or on the dedicated websites cbd.int/abs/ (Nagoya Protocol) or https://absch.cbd.int/ (ABS Clearing-House). +* Help: Get in contact with the corresponding office in your country +* Actions: First you need a prior informed consent (PIC). In order to use the resource, you must additionally negotiate an agreement (often referred to as Mutually Agreed Terms, MAT) on how to share resulting benefits. + +Reuse: +* In order to make your data reusable to others again, as an important element of the FAIR principles, the legal basis must be clarified. + ## Relevant tools and resources {% include toollist.html tag="compliance" %}